-
2023-506866-30-00
4
2024-08-19
HER2 positive or HER2-low metastatic breast cancer
-
2023-506823-28-00
4
2024-06-14
Adult patients with locally advanced/metastatic solid tumors
-
2023-506038-65-00
4
2024-04-15
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE
METASTATIC BREAST CA
-
2023-503341-60-00
4
2024-02-14
non-operable hepatocellular carcinoma
-
2024-518411-19-00
9
2023-12-04
Advanced HER2-Expressing Solid Tumors.
-
2022-502840-11-00
9
2023-11-28
Hepatocellular Carcinoma (Morpheus-Neo HCC)
-
2022-502476-23-00
4
2023-10-25
Treatment of immunotherapy-naive patients with previously untreated or
-
2022-502372-22-01
4
2023-10-19
Metastatic Breast Cancer HR+, HER2-
-
2022-502360-21-00
4
2023-10-12
GATA3-mutant, ER-positive, HER2-negative advanced or metastatic breast
-
2023-508267-69-00
3
2023-08-11
Subjects with Aadvanced solid tumors for whom life-prolonging therapie
-
2022-501505-13-00
1
2023-03-31
Metastatic melanoma
-
2022-500652-37-00
4
2022-12-01
Advanced melanoma refractory to prior checkpoint inhibitor therapy
-
2024-514714-12-00
10
2022-11-11
Metastatic Pancreatic Ductal Adenocarcinoma
-
2023-504270-38-00
4
2022-10-18
In participants with PD-L1–positive and systemic therapy–naive R/M
SCC
-
2024-510649-33-00
9
2022-09-02
Advanced/metastatic hepatocellular carcinoma (HCC)
-
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
-
2024-511361-11-00
10
2022-03-25
Advanced dedifferentiated liposarcoma
-
2024-513707-14-00
5
2022-01-14
Only patients with oncologic locally advanced or metastatic tumour (lu
-
2024-517241-13-00
4
2021-10-22
metastatic colorectal cancer
-
2022-502774-17-00
7
2021-10-04
Advanced or metastatic gastric and gastro-esophageal junction (GEJ) ad
-
2024-513870-23-00
5
2021-06-28
Locally Advanced or Metastatic Unresectable Urothelial Cancer
-
2024-513982-38-00
5
2021-03-17
Metastatic or unresectable advanced rare sarcomas
-
2024-516111-25-00
5
2020-11-09
Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Per
-
2024-513984-22-00
4
2020-03-17
Patients with metastatic GIST